EN
HI
Summary
As of 6 Oct, 2026, Orchid Pharma stock price is ₹965.9. During the trading session, the stock has moved between an intraday low of ₹960.00 and an intraday high of ₹1003.20. Over the last 52 weeks, Orchid Pharma has traded between ₹480.00 and ₹1143.50.
The stock has recorded a trading volume of 68,202 shares,. Its Average Traded Price (ATP) is ₹972.89, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 100 @ ₹965.90.
Orchid Pharma has an upper circuit limit of ₹1188.00 and a lower circuit limit of ₹792.00. The total value traded stands at ₹6.64 CR, and the delivery percentage for the day is 39.8%.
The stock is currently traded with a market lot size of 1. Orchid Pharma also offers a dividend yield of 0%.
Orchid Pharma Share Price Chart
Orchid Pharma Share Key Metrics
Volume
68202.00
Market Cap
5784.31 CR
LTQ@LTP
100@965.90
ATP
972.89
Var Margin
22.59 %
Circuit Range
792-1188
Delivery %
39.8 %
Value
6.64 CR
ASM/GSM
No
Market Lot
1
Orchid Pharma Fundamentals
P/E Ratio
685.2
P/B Ratio
3.79
Div. Yield
0
Sector P/E
42.73
Sector P/B
3.55
Sec. Div. Yield
0.52
Orchid Pharma Resistance and Support
Pivot 988.93
Resistance
First Resistance
1013.21
Second Resistance
1036.43
Third Resistance
1060.71
Support
First Support
965.71
Second Support
941.43
Third Support
918.21
Orchid Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Oct 05 2026 | 990.45 | 965.9 | -2.43% | 1003.2 | 960 |
| Thu Oct 01 2026 | 997.65 | 990 | -0.70% | 1012.15 | 964.65 |
| Wed Sep 30 2026 | 1014.9 | 997 | -1.76% | 1034.4 | 990 |
Orchid Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-14 | Quarterly Results |
| 2026-05-25 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-12 | Quarterly Results |
| 2026-08-01 | Allotment of Equity Shares |
Orchid Pharma News
Orchid Pharma Ltd - 524372 - Intimation Under Regulation 30- Trading Approval Of Equity Shares Issued And Allotted Under Scheme Of Amalgamation
Orchid Pharma has informed that 44,586,052 new equity shares, allotted under a scheme of amalgamation sanctioned by NCLT, have been listed and admitted to dealings on the National Stock Exchange and BSE, effective September 23, 2026. This facilitates trading of the shares post-merger.
Sep 23 2026 20:00:35
Orchid Pharma Ltd - 524372 - Intimation Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirement Regulations), 2015
Orchid Pharma has purchased land in Patibulum Village, Kancheepuram District, Tamil Nadu. This acquisition resolves a prior lease dispute with DBS Bank India Limited, providing the company with clear and permanent ownership of the property.
Sep 22 2026 21:21:54
Orchid Pharma Management
| Name | Position |
|---|---|
| Ram Gopal Agarwal | Chairman |
| Manish Dhanuka | Managing Director |
Orchid Pharma Similar Stocks
Sanofi India Ltd.
3024.20
-13.20 (0.43%)
Nephrocare Health Services Ltd.
637.65
-11.30 (1.74%)
Kovai Medical Center & Hospital Ltd.
5963.00
-30.50 (0.51%)
Morepen Laboratories Ltd.
135.29
1.57 (1.17%)
Senores Pharmaceuticals Ltd.
1321.20
-28.40 (2.10%)
IOL Chemicals And Pharmaceuticals Ltd.
205.71
-3.68 (1.76%)
Artemis Medicare Services Ltd.
324.10
-12.30 (3.66%)
FDC Ltd.
331.30
-4.60 (1.37%)
Gujarat Themis Biosyn Ltd.
373.60
-8.20 (2.15%)
Supriya Lifescience Ltd.
899.55
-31.45 (3.38%)
Orchid Pharma FAQs
The Buying Price of Orchid Pharma share is 965.9 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Orchid Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Orchid Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Orchid Pharma shares is 685.2. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Orchid Pharma shares is 3.79. Useful to assess the stock's value relative to its book value.
To assess Orchid Pharma’s valuation compare Sector P/E, P/B which are 42.73 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Orchid Pharma is 5784.31 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Orchid Pharma share price is 1143.50 & 480.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Orchid Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ORCHPHARMA
Or Download Choice FinX App
Invest in ORCHPHARMA
